• $15.3M
    Market Cap
  • -68.22%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
200.0M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
151,216
N/A
N/A
N/A
220,095
0.00%
220,095
N/A
Gross Profit
199.8M
N/A
0
+100.00%
-220,095
0.00%
-220,095
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.1M
-2.49%
-4.2M
+3.03%
-4.1M
+938.88%
-392,859
N/A
Depreciation and Amortization Expense
6,874
+265.64%
1,880
-5.05%
1,980
+56.40%
1,266
N/A
Total Operating Expenses
13.5M
+22.81%
11.0M
+43.60%
7.6M
+182.53%
2.7M
N/A
Operating Profit
-13.5M
+22.81%
-11.0M
+43.60%
-7.6M
+182.53%
-2.7M
N/A
Interest Income
223,815
-27.63%
309,251
+24.15%
249,092
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-40,192
N/A
Interest Income and Expense and Net
223,815
-27.63%
309,251
+24.15%
249,092
+719.76%
-40,192
N/A
Total Nonoperating Income and Expense
223,815
-27.63%
309,251
+142.70%
-724,243
-1,901.96%
40,192
N/A
Income before Taxes
-13.5M
+22.81%
-11.0M
+43.60%
-7.6M
+182.53%
-2.7M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-13.2M
+24.28%
-10.7M
+27.45%
-8.4M
+24.47%
-6.7M
N/A
Net Income from Continuing Operations Applicable to Common
-13.2M
+24.28%
-10.7M
+27.45%
-8.4M
+24.47%
-6.7M
N/A
Basic EPS and Net Income
-6.64
-23.94%
-8.73
+1,308.06%
-0.62
-27.06%
-0.85
N/A
Diluted EPS and Net Income
-6.64
-23.94%
-8.73
+1,308.06%
-0.62
-27.06%
-0.85
N/A
Basic Weighted Average Shares
2.0M
+63.48%
1.2M
-90.96%
13.5M
+70.99%
7.9M
N/A
Diluted Weighted Average Shares
2.0M
+63.48%
1.2M
-90.96%
13.5M
+70.99%
7.9M
N/A
Balance Sheet
Cash and Cash Equivalents
4.0M
-59.99%
10.0M
+19.23%
8.4M
+25,685.61%
32,586
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.0M
-59.99%
10.0M
+19.23%
8.4M
+25,685.61%
32,586
N/A
Total Current Assets
4.3M
-57.29%
10.1M
+19.08%
8.5M
+1,067.15%
727,596
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
5,174
-25.49%
6,944
+203.63%
2,287
+125.77%
1,013
N/A
Total Long-Term Assets
2,167
-42.85%
3,792
0.00%
3,792
-36.66%
5,987
N/A
Total Assets
4.3M
-57.26%
10.1M
+18.83%
8.5M
+994.77%
778,174
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
863,564
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
43,728
N/A
Total Current Liabilities
1.6M
-40.83%
2.7M
+224.59%
826,875
-38.04%
1.3M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
50,000
-54.70%
110,380
N/A
Total Long-Term Liabilities
N/A
N/A
4.4M
+20,414.96%
21,350
-99.51%
4.4M
N/A
Total Liabilities
1.6M
-40.83%
2.7M
+224.59%
826,875
-86.94%
6.3M
N/A
Retained Earnings
-39.0M
+51.46%
-25.7M
+70.67%
-15.1M
+124.47%
-6.7M
N/A
Total Stockholders Equity
2.7M
-63.19%
7.4M
-3.29%
7.7M
+238.57%
-5.6M
N/A
Total Shares Outstanding
2.3M
+31.17%
1.8M
-86.31%
13.0M
+58.93%
8.2M
N/A
Cash Flow
Cash from Operating Activities
-12.6M
+71.28%
-7.4M
+108.41%
-3.5M
+193.03%
-1.2M
N/A
Capital Expenditures
5,104
-21.92%
6,537
+100.89%
3,254
+42.78%
2,279
N/A
Cash from Investing Activities
-5,104
-21.92%
-6,537
+100.89%
-3,254
+42.78%
-2,279
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.6M
-26.54%
9.0M
-24.56%
11.9M
+860.24%
1.2M
N/A
Financials Ratio
Gross Margin
99.92%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-6.73%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-183.21%
+60.34%
-114.27%
-36.44%
-179.77%
N/A
N/A
N/A
Return on Equity
-260.11%
+84.76%
-140.78%
-81.96%
-780.59%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.72
-27.81%
3.77
-63.31%
10.27
N/A
N/A
N/A
Cash Ratio
2.52
-32.38%
3.73
-63.27%
10.16
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow